The Enrofloxacin Market is estimated to be valued at US$ 470.4 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Overview:

Enrofloxacin belongs to fluoroquinolones family of synthetic broad-spectrum antibiotic used for treating respiratory, skin and soft tissue, and ... Read more

Enrofloxacin is a broad-spectrum fluoroquinolone antimicrobial agent used for the treatment of bacterial infections in various livestock such as cattle, pigs, and poultry. It provides effective treatment for respiratory and enteric infections caused by Gram-positive and Gram-negative bacteria.

The global enrofloxacin market is estimated to be valued at US$ 470.4 Mn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted ... Read more

Enrofloxacin is a fluoroquinolone antimicrobial agent that is primarily used to treat bacterial infections in animals. It works by interfering with the enzyme called DNA gyrase which is required for bacterial DNA replication. Enrofloxacin is commonly used to treat respiratory diseases, skin infections, urinary tract infections, and septicemia in a variety of animal species including cattle, pigs, and poultry. It has a broad spectrum of activity against both gram-positive and gram-negative ... Read more

Enrofloxacin is a fluoroquinolone carboxylic acid antibacterial drug used primarily in veterinary medicine. It belongs to the class of fluoroquinolones which are broad-spectrum antibiotics. Discovered by scientists at Bayer AG in Germany in the 1980s, Enrofloxacin was one of the earliest quinolones to be used for veterinary applications. Over the years, it has emerged as one of the most versatile antibacterial drugs for treating infections in a wide range of livestock and companion animals. ... Read more